Characterizing Emerging Canine H3 Influenza Viruses

0301 basic medicine QH301-705.5 EMC OR-01 Guinea Pigs Communicable Diseases, Emerging Influenza A Virus, H3N8 Subtype 03 medical and health sciences Dogs Zoonoses Influenza, Human Animals Humans Dog Diseases Biology (General) Medicine and health sciences Mice, Inbred BALB C 0303 health sciences Biology and life sciences Influenza A Virus, H3N2 Subtype Ferrets RC581-607 United States 3. Good health Mice, Inbred C57BL Research and analysis methods Influenza A virus Mice, Inbred DBA Immunologic diseases. Allergy Research Article
DOI: 10.1371/journal.ppat.1008409 Publication Date: 2020-04-14T17:35:32Z
ABSTRACT
The continual emergence of novel influenza A strains from non-human hosts requires constant vigilance and the need for ongoing research to identify strains that may pose a human public health risk. Since 1999, canine H3 influenza A viruses (CIVs) have caused many thousands or millions of respiratory infections in dogs in the United States. While no human infections with CIVs have been reported to date, these viruses could pose a zoonotic risk. In these studies, the National Institutes of Allergy and Infectious Diseases (NIAID) Centers of Excellence for Influenza Research and Surveillance (CEIRS) network collaboratively demonstrated that CIVs replicated in some primary human cells and transmitted effectively in mammalian models. While people born after 1970 had little or no pre-existing humoral immunity against CIVs, the viruses were sensitive to existing antivirals and we identified a panel of H3 cross-reactive human monoclonal antibodies (hmAbs) that could have prophylactic and/or therapeutic value. Our data predict these CIVs posed a low risk to humans. Importantly, we showed that the CEIRS network could work together to provide basic research information important for characterizing emerging influenza viruses, although there were valuable lessons learned.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (80)
CITATIONS (38)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....